Sign in
4

Changes in Ownership

Viridian Therapeutics, Inc.\DE Filed Acc 0001104659-25-102606

Director bought 454,545 shares at $22.00 ($9,999,990)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Fairmount Funds Management LLC Director 2025-10-23 Purchase +454,545 $22.00 $9,999,990 3,914,458 I: show line 1 in the form
Open-market purchases · 454,545 sh · avg $22.00 · $9,999,990
Loading xslF345X05/tm2529526-1_4seq1.xml…